Iatrogenic calcinosis cutis following nadroparin injection

International Journal of Dermatology

Volumn 44, Issue 10, 2005, Pages 855-857

  Giorgini, Simonetta ^a   Martinelli, Canio ^a   Massi, Daniela ^a   Lumini, Annalisa ^a   Mannucci, Marco ^a   Giglioli, Leonetto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CREATININE; GLUCOSE; NADROPARIN; NITROGEN; PARATHYROID HORMONE; PHOSPHATE; UREA;

ACANTHOSIS; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM TRANSPORT; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; DRUG INDUCED DISEASE; FATALITY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; IATROGENIC DISEASE; KIDNEY TRANSPLANTATION; LABORATORY TEST; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; SKIN BIOPSY; SKIN CALCIFICATION; ULCER; UREA NITROGEN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CALCINOSIS; HUMANS; IATROGENIC DISEASE; INJECTIONS, SUBCUTANEOUS; MALE; NADROPARIN; SKIN DISEASES; VENOUS THROMBOSIS;

EID: 27544432552     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02310.x     Document Type: Article

References (13)

1. Walsh JS, Fairley JA. Calcifying disorders of the skin. J Am Acad Dermatol 1995; 33: 693-706.
2. Schoenfeld RJ, Grekin JN, Mehregan A. Calcium deposition in the skin: a report of four cases following electroencephalography. Neurology 1965; 15: 477-480.
3. Johnson RC, Fizpatrick JE, Hahn DE. Calcinosis cutis following electromyographic examination. Cutis 1993; 52: 161-164.
4. Puig L, Rocamora PL, Romani J, et al. Calcinosis cutis following chloride paste application for auditory-brainstem evoked potentials recording. Pediatr Dermatol 1998; 15: 27-30.
5. Goldminz D, Barnhill R, McGuire J, et al. Calcinosis cutis following extravasation of calcium chloride. Arch Dermatol 1988; 124: 922-925.
6. Millard TP, Harris AJ, MacDonald DM. Calcinosis cutis following intravenous infusion of calcium gluconate. Br J Dermatol 1999; 140: 184-186.
7. Touart MDM, San P. Cutaneous deposition diseases. Part II. J Am Acad Dermatol 1998; 39: 527-544.
8. Fox JG, Walli RK, Jaffray B, et al. Calcified subcutaneous nodules due to calcium heparin injections in a patient with chronic renal failure. Nephrol Dial Transplant 1994; 9: 187-188.
9. Mayou SC, Kelly SE, McGibbon DH. Local cutaneous sensitivity to subcutaneous heparin. Br J Dermatol 1987; 117: 664-665.
10. Klein GF, Kofler H, Wolf H, et al. Eczema-like, erythematous, infiltrated plaques: a common side effect of subcutaneous heparin therapy. J Am Acad Dermatol 1989; 21: 703-707.
11. Weitz JI. Low molecular-weight heparins. N Engl J Med 1997; 337: 688-698.
12. Handeland GF, Abildgaard U, Holm HA, et al. Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin. Eur J Clin Pharmacol 1990; 39: 107-112.
13. Van Haren FMP, Ruiter DJ, Hilbrands LB. Nadroparin-induced calcinosis cutis in renal transplantation recipients. Nephron 2001; 87: 279-282.